Volume 3 Number 2
Editorial
30
Retrograde approach for chronic total occlusion: present status and prospectsEuroInterv.2007;3:169-173
Letters to the Editor
31
Chronic total occlusions (CTO): the paradox of “premature balloon support”EuroInterv.2007;3:175-177
EAPCI column
Clinical research
33
Retrograde approach to coronary chronic total occlusions: preliminary single European centre experienceEuroInterv.2007;3:181-187
34
Contemporary treatment of patients with chronic total occlusion: critical appraisal of different state-of-the-art techniques and devices García-García H, Kukreja N, Daemen J, Tanimoto S, van Mieghem CAG, Gonzalo N, van Weenen S, van der Ent M, Sianos G, de Feyter PJ, Serruys PW
EuroInterv.2007;3:188-196
35
Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registrySeabra-Gomes R, Eduardo Sousa J, Sousa A, Teles R, Pereira H, Farto Abreu P, Adao M, Marques A, Gama Ribeiro V, Mourao L, Santos R, Cyrne Carvalho H, for the PORTuguese prospective non-randomised multicentre Outcomes Trial of sirolimus-eluting stent in small native coronary arteries (PORTO Trial) Investigators and Committees
EuroInterv.2007;3:197-205
36
Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)Beijk M, Neumann F-J, Wiemer M, Grube E, Haase J, Thuesen L, Hamm C, Veldhof S, Dorange C, Serruys PW, Piek J
EuroInterv.2007;3:206-212
37
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stentsDawkins K, Grube E, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptmann K, Marco J, Wijns W, Popma J, Weissman N, Koglin J, Russell ME, on behalf of the TAXUS VI investigators
EuroInterv.2007;3:213-221
38
Clinical results of two year dual antiplatelet therapy after primary percutaneous coronary intervention with paclitaxel-eluting stents: a single centre studyEuroInterv.2007;3:222-227
39
A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategyDurand E, Hamm C, Macaya C, Georges J-L, Coste P, Wolf J, Slama M, Husted S, Mosseri M, Lafont A, for the Prospective RAndomised placebo Controlled trial to assess the role of GP IIb/IIIa blockade by integrilin in patients with troponin Increase and non persistent ST segment elevation acute Coronary syndromE study (PRACTICE) investigators
EuroInterv.2007;3:228-234
41
Rapid ventricular pacing can reduce heart motion and facilitate stent deployment to the optimal position during coronary artery stenting: initial experience EuroInterv.2007;3:239-242
42
Diffusion-weighted imaging to compare different cerebral protection devices in carotid artery stentingEuroInterv.2007;3:243-248
43
A novel ultra-thin bare metal stent (BMS): results from a worldwide registryBlanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp M, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D, on behalf of MATSURI investigators
EuroInterv.2007;3:249-255
44
‘Fused-Gold’ vs. ‘Bare’ stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP StudyFort S, Kornowski R, Silber S, Lewis B, Bilodeau L, Almagor Y, van Remortel E, Morice M-C, Colombo A
EuroInterv.2007;3:256-261
45
Registry on a new T technique for bifurcation coronary lesions: the Utrech-“T”- experience EuroInterv.2007;3:262-268
Expert review
46
Proximal protection in carotid artery stenting: rationale and recent findingsEuroInterv.2007;3:269-274
47
Uncoupling protein 2-mediated thermogenesis in vulnerable atherosclerotic plaquesEuroInterv.2007;3:275-279
Experimental research
48
Coronary sinus stent implantation improves acute ischaemic mitral valve regurgitation; Manginas A, Karagiannis S, Karatasakis G, Papalois A, Papalambrou A, Daphnomili P, Kaklamanis L, Khaldi L, Cokkinos D
EuroInterv.2007;3:280-285
Technical report
Image in cardiology
51
Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents EuroInterv.2007;3:290-291
Volume 3 Number 2 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Biosensors
- Boston Scientific
- Cordis, a Johnson & Johnson company
- GE Healthcare
- Hexacath
- Invatec
- Medtronic
- Orbus Neich
- Terumo
- Xtent Inc.



